Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

CUSIP: 04635X102

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,127,897
Total 13F shares
58,322,222
Share change
-261,385
Total reported value
$311,449,455
Put/Call ratio
1525%
Price per share
$5.34
Number of holders
112
Value change
-$2,818,099
Number of buys
51
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 04635X102?
CUSIP 04635X102 identifies ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q1 2025

As of 31 Mar 2025, Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,322,222 shares. The largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, BlackRock, Inc., FCPM III SERVICES B.V., Fairmount Funds Management LLC, TCG Crossover Management, LLC, VANGUARD GROUP INC, and VR ADVISER, LLC. This page lists 112 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.